The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS) meeting in Philadelphia (Sept. 29–Oct. 1); the editor-in-chief’s open letter to the National Rifle Association; tips on how to take feedback on board as a vascular trainee; and the presidential addresses from two recent regional society meetings that set out ideas for helping vascular surgery thrive as a specialty.
The SVS Executive Board highlights details of the most recent Society for Vascular Surgery (SVS) elections to inform members and further strengthen the process.
2. EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated TBAD in subacute phase compared to medical management
TEVAR carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the acute phase compared to those treated in the subacute phase and those managed medically.
4. NESVS 2022: Study illustrates relationship between increased distance from medical center and higher treatment costs among complex aortic patients
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the new science being presented at the 2022 annual meeting of the New England Society for Vascular Surgery (NESVS).
Christopher Audu, MD, recently took the Registered Physician in Vascular Interpretation (RPVI) exam. He tells how there are multiple voices in the ears and heads of vascular trainees, and how to decipher this overwhelming and/or contradictory feedback.
The Society for Vascular Surgery (SVS) wants members’ research on vascular disease for the 2023 Vascular Research Initiatives Conference (VRIC) and the 2023 Vascular Annual Meeting (VAM).
Vincent Rowe, MD, and Raghu Motaganahalli, MD, delivered Presidential Addresses at the Western Vascular Society (WVS) and the Midwestern Vascular Surgical Society (MVSS) that spelled out ways in which vascular surgery can advance—and thrive.
Positively interacting with best practice advisory notifications is correlated with an increased rate of abdominal aortic aneurysm (AAA) screening, according to an analysis of all patients who triggered these communications alerts in an electronic medical record (EMR) system at a single tertiary medical center.
The Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid device—used to treat aortic arch disease—under the inpatient prospective payment system (IPPS).
The Abre venous stent demonstrated three-year primary patency rates of 97.1%, 76.5% and 70.4% respectively for non-thrombotic iliac vein lesion (NIVL), acute deep vein thrombosis (DVT), and post-thrombotic syndrome (PTS) patient populations within the ABRE clinical study.